To maintain vaccine efficacy, WHO regularly updates influenza vaccine strains based on global epidemiological, virological, ...

The immune system responds to an infection by producing antibodies that recognize and bind to the cell surface of the ...

called T follicular helper cells, indirectly controls the anti-influenza response. ... Aug. 19, 2024 — The avian influenza virus needs to mutate to cross the species barrier and to infect and ...

Yearly administration of the influenza vaccine is the main strategy to prevent influenza in immunocompromised patients. Here, we reviewed the recent literature regarding the clinical significance ...

Older adults who were exposed to seasonal flu viruses that circulated prior to 1968 are more likely to have some protection ...

SK bioscience, a global innovative vaccine and biotech company committed to promoting human health from prevention to cure, ...

Developments include cell-based and recombinant DNA technologies. The global influenza vaccine market is projected to cross $14b by 2032, according to DelveInsight. The sector’s expansion is ...

Commercially available vaccines include egg- or cell-based inactivated, live attenuated and recombinant influenza vaccines. To develop more effective vaccines, a deeper understanding of influenza ...

Highly pathogenic avian influenza (HPAI) readily infected cells from milk-producing organs in dairy cows, but beef cells held ...